Definition and epidemiology
The WHO defines post-COVID-19 condition as occurring in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from onset, with symptoms lasting at least 2 months that cannot be explained by an alternative diagnosis. The CDC uses a broader window, defining long COVID as symptoms persisting more than 4 weeks after initial infection. Both definitions agree the condition is diagnosed clinically after excluding other causes.
Estimates of prevalence vary widely by definition, population, and study design, but roughly 10-20% of people infected with SARS-CoV-2 report at least one persistent symptom beyond the acute phase, with a smaller subset having symptoms severe enough to impair daily function. Risk appears higher after more severe acute illness, but long COVID also occurs after mild or even asymptomatic infection.
- More common in women than men
- Risk increases with number of reinfections
- Vaccination before infection is associated with reduced risk, though not elimination of risk
- Can affect children, though reported rates are generally lower than in adults
- Long COVID = symptoms persisting ≥2 months, starting within 3 months of infection, per WHO definition
- Most common symptoms: fatigue, dyspnea, cognitive impairment ('brain fog')
- Diagnosis is clinical, by exclusion — no confirmatory biomarker exists
- Routine labs/imaging are typically normal
- Vaccination before infection reduces risk but does not eliminate it
- Significant symptomatic overlap with ME/CFS and POTS
- Management is supportive/rehabilitative; pacing is key, aggressive exercise can worsen post-exertional malaise
- No approved disease-modifying drug therapy currently exists
Etiology and risk factors
The exact cause is not fully understood and is likely multifactorial. Proposed mechanisms include persistent viral antigen or reservoir, immune dysregulation, autoimmunity, endothelial dysfunction and microvascular injury, reactivation of latent viruses (such as Epstein-Barr virus), and dysbiosis of the gut microbiome.
Risk factors
- Severity of acute infection (ICU admission, high viral load)
- Female sex
- Pre-existing comorbidities (obesity, diabetes, asthma)
- Multiple SARS-CoV-2 reinfections
- Unvaccinated status at time of infection
- Certain acute-phase findings: lymphopenia, specific autoantibodies, Epstein-Barr virus reactivation
- Mental health conditions predating infection (anxiety, depression) are associated with higher reported symptom burden
Pathophysiology
No single unifying mechanism has been established; current evidence supports several overlapping pathways:
- Immune dysregulation: persistent low-grade inflammation, altered T-cell responses, and autoantibody production
- Viral persistence: SARS-CoV-2 RNA or protein detected in tissues (gut, lymphoid tissue) months after acute infection in some patients
- Endothelial and microvascular dysfunction: contributes to fatigue, exercise intolerance, and possibly microclots
- Autonomic dysfunction: implicated in postural tachycardia and dysautonomia-type symptoms seen in a subset of patients
- Mitochondrial dysfunction: proposed contributor to post-exertional malaise, similar to mechanisms suggested in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
The overlap with ME/CFS is notable: a subset of long COVID patients meet diagnostic criteria for ME/CFS, suggesting shared pathophysiology.
Clinical features
Symptoms are highly heterogeneous and can involve nearly every organ system. More than 200 symptoms have been reported in the literature.
Most common
- Fatigue (often with post-exertional malaise)
- Dyspnea or exercise intolerance
- Cognitive impairment ('brain fog'): poor concentration, memory issues
- Sleep disturbance
Other frequently reported features
- Cardiovascular: palpitations, chest pain, postural orthostatic tachycardia syndrome (POTS)-like symptoms
- Respiratory: persistent cough, reduced exercise tolerance
- Neurological: headache, paresthesias, anosmia/dysgeusia (loss of smell/taste)
- Psychiatric: anxiety, depression, new-onset mood disorders
- Musculoskeletal: myalgia, arthralgia
- Gastrointestinal: diarrhea, abdominal pain
- Dermatologic: rash, hair loss
Symptoms may be persistent, relapsing-remitting, or progressive, and often fluctuate with physical or cognitive exertion.
Diagnosis
Long COVID is a clinical diagnosis made by history (confirmed or probable prior SARS-CoV-2 infection plus a compatible symptom timeline) after excluding alternative explanations. There is no single confirmatory biomarker or test.
Recommended workup to exclude alternative causes
| Test | Purpose |
|---|---|
| CBC, metabolic panel, TSH | Exclude anemia, metabolic, thyroid causes of fatigue |
| CRP/ESR | Screen for ongoing inflammatory process |
| Chest imaging/PFTs | If persistent dyspnea or cough |
| ECG, troponin, echocardiogram | If chest pain, palpitations, or concern for myocarditis |
| Orthostatic vital signs/tilt table | If suspected dysautonomia or POTS |
| Cognitive screening | If prominent brain fog |
Routine labs and imaging are frequently normal, which is itself a diagnostic feature supporting the clinical label once other causes are excluded.
Differential diagnosis
- Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
- Major depressive disorder or generalized anxiety disorder
- Hypothyroidism
- Anemia
- Obstructive sleep apnea
- Postural orthostatic tachycardia syndrome (primary)
- Fibromyalgia
- Deconditioning from prolonged illness or hospitalization
- Post-ICU syndrome (if preceded by critical illness)
- Undiagnosed autoimmune disease
Management
Management is supportive and symptom-directed; no disease-modifying therapy is currently approved or universally endorsed by major guideline bodies (WHO, CDC, NICE). Management should be individualized and multidisciplinary.
General principles
- Pacing and energy conservation strategies, especially to avoid post-exertional malaise
- Graded return to activity only as tolerated; aggressive exercise programs are not recommended if post-exertional malaise is prominent
- Pulmonary rehabilitation for persistent respiratory symptoms
- Cognitive rehabilitation strategies for brain fog
- Treat specific identified complications (e.g., POTS management with volume expansion, compression garments, and rate-controlling agents such as beta-blockers if needed)
- Address comorbid depression/anxiety with standard psychotherapy and, if indicated, antidepressants
- Sleep hygiene measures and treatment of underlying sleep disorders
Pharmacologic approach
No specific antiviral or immunomodulatory drug is currently recommended as standard of care for long COVID itself; several agents (e.g., antivirals, anticoagulants, immunomodulators) have been studied in trials with mixed or inconclusive results. Symptom-targeted agents include analgesics for pain, melatonin or other sleep aids for insomnia, and beta-blockers for POTS-type palpitations. NICE, WHO, and CDC guidance converge on a multidisciplinary, rehabilitative approach rather than a single pharmacologic cure.
Prevention
- Vaccination against COVID-19 before infection reduces (but does not eliminate) the risk of long COVID
- Avoiding reinfection is associated with lower cumulative risk
Complications and prognosis
Many patients improve gradually over 12-24 months, though a subset experience prolonged or relapsing symptoms lasting years. Functional impairment can be significant, with some patients unable to return to prior work or activity levels.
Complications
- Chronic fatigue meeting ME/CFS criteria
- New-onset dysautonomia (POTS)
- Mental health decline (depression, anxiety, reduced quality of life)
- Reduced exercise capacity and deconditioning
- Possible increased long-term risk of cardiovascular and metabolic events after SARS-CoV-2 infection, an area of ongoing study
Prognosis is generally more favorable in those with mild acute illness and improves with time and supportive management, though recovery trajectories are highly variable and not fully predictable at an individual level.
FATIGUED: Fatigue, Autonomic symptoms (POTS), Trouble concentrating (brain fog), Insomnia, GI symptoms, Unresolved dyspnea, Exercise intolerance, Depression/anxiety
Practice questions
1. A 34-year-old woman presents 4 months after a confirmed mild SARS-CoV-2 infection with persistent fatigue, difficulty concentrating, and exertional dyspnea. Routine CBC, metabolic panel, TSH, chest X-ray, and ECG are all normal. Which of the following is the most appropriate next step in management?
2. A 28-year-old man reports palpitations and lightheadedness when standing, occurring 5 months after COVID-19 infection. Orthostatic vital signs reveal a heart rate increase of 35 beats per minute within 10 minutes of standing without a significant drop in blood pressure. Which condition best explains this presentation?
3. Which statement about the epidemiology and prevention of long COVID is most accurate based on current evidence?
Frequently asked questions
What causes long COVID?
The exact cause is unknown, but proposed mechanisms include immune dysregulation, persistent viral antigen, endothelial and microvascular dysfunction, reactivation of latent viruses like Epstein-Barr virus, and autonomic nervous system disruption. It is likely multifactorial rather than a single process, and research is ongoing to determine which mechanism dominates in different patient subgroups.
What are the first symptoms of long COVID?
The most commonly reported early and persistent symptoms are fatigue, shortness of breath or reduced exercise tolerance, and cognitive difficulties often called brain fog. Other early features can include sleep disturbance, palpitations, muscle or joint pain, and loss of smell or taste. Symptoms typically continue or emerge after the acute infection has resolved.
How is long COVID diagnosed?
Long COVID is diagnosed clinically based on a history of SARS-CoV-2 infection and persistent symptoms lasting at least 2 months, starting within 3 months of infection, after excluding other explanations. Doctors typically order basic blood tests, thyroid function, and targeted imaging or cardiac studies to rule out alternative causes, since no single test confirms the diagnosis.
Is long COVID curable?
There is no single cure, but many people improve gradually over 12 to 24 months with supportive care. Treatment focuses on managing individual symptoms, pacing activity to avoid post-exertional malaise, and rehabilitation. A subset of patients have prolonged symptoms lasting years, so outcomes vary significantly between individuals.
Long COVID vs chronic fatigue syndrome — what is the difference?
Long COVID is specifically triggered by SARS-CoV-2 infection, while chronic fatigue syndrome (ME/CFS) can follow various infections or occur without a clear trigger. However, a significant subset of long COVID patients go on to meet full diagnostic criteria for ME/CFS, and the two conditions share overlapping symptoms and proposed mechanisms such as post-exertional malaise and autonomic dysfunction.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: U09.9
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.